Literature DB >> 16434477

APRO4 negatively regulates Src tyrosine kinase activity in PC12 cells.

Zohra Rahmani1.   

Abstract

The Src nonreceptor tyrosine kinase plays an important role in multiple signalling pathways that regulate several cellular functions including proliferation, differentiation and transformation. The activity of Src is tightly regulated in vivo and can be modulated by interactions of its SH2 and SH3 domains with high-affinity ligands. APRO4 (anti-proliferative 4) belongs to a new antiproliferative gene family involved in the negative control of the cell cycle. This report shows that APRO4 associates with Src via its C-terminal proline-rich domain, and downregulates Src kinase activity. Moreover, overexpression of APRO4 leads to inhibition of neurite outgrowth and Ras/MAP kinase signalling in PC12 cells. Furthermore, the kinetics of endogenous Src inactivation correlates with an increase in endogenous APRO4 co-immunoprecipitation in FGF-stimulated PC12 cells. Finally, downregulation of endogenous APRO4 by expression of antisense RNA induces the activation of Src and spontaneous formation of neurites in PC12 cells. Therefore, by controlling the basal threshold of Src activity, APRO4 constitutes an important negative regulatory mechanism for Src-mediated signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434477     DOI: 10.1242/jcs.02778

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

1.  Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.

Authors:  Shahana Majid; Altaf A Dar; Varahram Shahryari; Hiroshi Hirata; Ardalan Ahmad; Sharanjot Saini; Yuichiro Tanaka; Angela V Dahiya; Rajvir Dahiya
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

2.  HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.

Authors:  C-H Chen; W-H Chang; K-Y Su; W-H Ku; G-C Chang; Q-S Hong; Y-J Hsiao; H-C Chen; H-Y Chen; R Wu; P-C Yang; J J W Chen; S-L Yu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

3.  Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells.

Authors:  Jingwei Yu; Yingsha Zhang; Zhongxia Qi; Daniel Kurtycz; Guido Vacano; David Patterson
Journal:  Gene Expr       Date:  2008

4.  BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Authors:  Shahana Majid; Altaf A Dar; Ardalan E Ahmad; Hiroshi Hirata; Kazumori Kawakami; Varahram Shahryari; Sharanjot Saini; Yuichiro Tanaka; Angela V Dahiya; Gaurav Khatri; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2009-02-12       Impact factor: 4.944

5.  The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

Authors:  Yi-Hung Ou; Pei-Han Chung; Fu-Fei Hsu; Te-Ping Sun; Wen-Ying Chang; Sheau-Yann Shieh
Journal:  EMBO J       Date:  2007-08-09       Impact factor: 11.598

Review 6.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

7.  Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

Authors:  Boya Deng; Yang Zhao; Wenfeng Gou; Shuo Chen; Xiaoyun Mao; Yasuo Takano; Huachuan Zheng
Journal:  Tumour Biol       Date:  2013-05-09

8.  The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.

Authors:  Wen-feng Gou; Xue-feng Yang; Dao-fu Shen; Shuang Zhao; Yun-peng Liu; Hong-zhi Sun; Yasuo Takano; Rong-jian Su; Jun-sheng Luo; Hua-chuan Zheng
Journal:  Oncotarget       Date:  2015-08-14

9.  The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.

Authors:  Hua-Chuan Zheng; Hao-Yu He; Ji-Cheng Wu; Jing Li; Shuang Zhao; Gui-Feng Zhao; Hua-Mao Jiang; Xue-Wen Yu; Zhi-Jie Li
Journal:  Oncotarget       Date:  2017-03-14

10.  The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang; Kai-Hang Shi; Rui Zhang
Journal:  Front Genet       Date:  2022-09-16       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.